Last updated on December 2018

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer

Brief description of study

The purpose of this study is to evaluate the safety and efficacy of the study drug abemaciclib in participants with high risk, node positive, early stage, hormone receptor positive (HR+), human epidermal receptor 2 negative (HER2-), breast cancer.

Clinical Study Identifier: NCT03155997

Contact Investigators or Research Sites near you

Start Over

Aurelia Alexandru

Institutul Oncologic Dr Trestioreanu Bucuresti
Bucuresti, Romania
  Connect »

Mircea Dragos Median

Spitalul Clinic Filantropia
Bucuresti, Romania
  Connect »

Elena Ciubotaru

S.C. R.T.C. Radiology Therapeutic Center S.R.L.
Otopeni, Romania
  Connect »